March 05, 2009Even More Evidence Of Placebo Effect In Teen Depression TrialsA new study examining the safety of placebo arms in clinical trials of anti-depressants in teens is out in the American Journal of Psychiatry and, while it doesn't directly examine the placebo effect per se, it certainly shows that there is a sizable placebo effect in these trials, that the effect size of anti-depressants is modest and that the suicide attempts that cropped up among placebo arm patients happened after the teens were on an active treatment later in the trial. The paper is an analysis of data from the TADS Study (Treatment for Adolescents With Depression Study). It was a fairly long term study and involved 439 patients, aged 12 to 17 years, who were either given Prozac, CBT-alone, CBT and Prozac or placebo. After the first 12 weeks of the study, placebo patients either went into active treatment or left the study. The safety of placebo arms in depression trials among teens and kids has been questioned over possible harms caused by denying kids the wonders of active anti-depressant treatment and over what negative effects being in a placebo arm initially might present for later anti-depressant treatment. This new study sorts out most of these issues and there are several take-aways. 1. Placebo treatment didn't hurt teens, researchers found, so the ethical question of "denying" treatment is addressed. 2. The teens who were in the initial 12-week placebo arm did fairly well. Of kids on placebo-only for 12 weeks, 35 percent responded to their "treatment" while 58 percent of the other groups did (a very common 23 percent effect size for active treatments including CBT). 3. At week 36, the response rate was 82 percent in the initial placebo group and 83 percent in the active treatment groups, which certainly argues for some level of sustained placebo effect ("Patients who responded to placebo generally retained their response," the study authors note.) The remission rate was 48 percent in the initial placebo patients and 59 percent in the active treatment groups, so certainly not much of an argument can be made that offering kids a placebo limits their ability to respond to other treatments. (It also make me wonder, skeptically of course, about the various prevention paradigm claims made for anti-depressants.) 4. Although the authors don't address this point, I think you can reasonably make the case that the placebo effect exists in both kids and adults undergoing various depression treatments (or taking a placebo) and it ought to become a legitimate object of research. Certainly, a study by Arif Khan last year showed an enormous and long-last placebo effect among adults and a recent meta-study in the AJP showed a large placebo effect in a slew of depression trials in kids and teens. I'm not sure how much money NIMH is getting of the $1.1 billion in stimulus money designed to sort out which medical treatments work best (I'm dubious of how much of this money will actually create jobs but that's a separate issue), and it would make sense for NIMH to allocate some money to funding real world research on the placebo effect in depression treatment. There's too large of a consistent effect out there to not want to understand how large it is and, if possible, what's driving it (beyond psychological suggestion). 5. There were suicide attempts among initial placebo patients, mostly occurring when the patients either moved to active medication or psychotherapy or a combination. The authors note: "It is important to note that the large majority of suicide attempts among placebo/open patients (80 percent; 12/15) occurred after the period during which they were on the placebo. Thus, depressed adolescents assigned to placebo condition are for the most part able to tolerate the waiting period without significant clinical distress." 6. Anti-depressant true believers among doctors and advocates are simply running out of road when it comes to making the "anti-depressants for kids are awesome!" argument. Given that a WHO study recently lined up with the FDA black box warning on anti-depressants (at least through the age of 18) as well as with the British ban on their use in under-18s in finding an increased risk of suicide among kids and teens using anti-depressants, it's time for the true believers to reassess their arguments and perhaps argue for extreme caution in the use of anti-depressants in kids and teens, at a minimum. (I'm making no argument here about young adults and adults.) What's more, the obvious placebo effect apparent in these trials hardly argues in favor of casual anti-depressant use either. Perhaps, it's all really an argument for sugar pills painted to look like Prozac. Posted by Philip Dawdy at March 5, 2009 12:03 AM
del.icio.us
Digg it
reddit
Comments
It is so good to hear that no children were harmed by using placebo. The following is an article [partial] about a woman who recovered from a THIRTY [30] year depression while taking a placebo during a clinical trial. Kind of blows the mind!! http://www.ssristories.com/show.php?item=2055 This article reads: "And by the end of the study, Schonfeld seemed to be yet another person who owed a nearly miraculous recovery to the new generation of antidepressants -- in this case, venlafaxine, better known as Effexor.
Is it Prozac? Or Placebo?
There was a paper in PLoS Medicine which investigated the difference between AD and placebo for different levels of depression (mild to severe). It was interesting that the AD's performed as poorly for mild as severe; what was more interesting was how the placebo effect was significantly diminished for the severe whereas for mild it is as good as AD. All too often, mild depression is just normal response to life issues. Given time (placebo), it clears up on its own. As you have noted, there is a rush to drug. For severe which is more likely biological in origin and potentially life threatening, waiting for it to clear may not be wise. In this case, treatment of some sort seems to be the thing to do. Posted by: Tony at March 5, 2009 10:13 AMI don't know whether to laugh or cry when I see medical professionals assessing the "safety of placebo" with the implicit assumption that of course the "disease" of mental illness is much more dangerous than any psychotropic treatment they might be evaluating. The whole way in which the problem is constructed makes me weep. The most dangerous piece of the puzzle by far is the pyschotropic drug that's being evaluated. That possibility seems to be far off the radar screen of all the "scientists" listed at the heading of this article. Yet evidence everywhere in clinical practice is screaming that this is in fact the case. According to Philip's summary the only worrisome events on placebo were related in some way to active treatment and that's exactly what has been obscured in so many other "placebo arms" of other trials. So often "placebo events" turn out to be nothing of the sort. They are often withdrawal events dressed up as placebo events (because there is no active treatment right at the time of the event -- it was stopped abruptly shortly before). This in turn makes the active arm look more benign than it really is because the number of "events" are closer to the placebo arm (which was really a withdrawal arm). No treatment turns out not really to be no treatment -- it's abruptly stopped treatment. This is what's dangerous -- abrupt withdrawal -- not no treatment as the fearmongers and sickness sellers would have us believe. If you were really comparing active treatment to a true absence of all medicated treatment, especially over time, you would certainly see just how dangerous and ineffective it is. Posted by: Sara at March 5, 2009 02:52 PMI agree with Sara. So many of these placebo clinical trial patients are actually in withdrawal from another drug. This skews the trial results in favor of the active drug and against the placebo. I will always wonder if all these clinical trials among children actually did result in a suicide or two - contrary to what the authorities would have us believe. I have confirmation, with all the legal papers from Solvay, that a man, with no previous criminal record, who was in a clinical trial for Luvox in 1993 [yes! the drug Eric Harris of Columbine was taking] murdered another person during the clinical trial. This fact was never made known to the public. The man was sentenced to 15 years in prison and upon early release has undoubtedly signed papers of a secret settlement type. So how many children actually committed suicide during the clinical trials? Was this kept a secret also - with a big payment involved? Posted by: Rosie at March 5, 2009 08:04 PMSSRIs seem to still be useful in entrenched OCD not responding to cognitive behaviour therapy, or at least the pills may help the CBT get going. A very rare severe more biological depression may benefit too. But nearly all depressed kids and teens need the right mix of psychotherapy, lifestyle changes like regular bedtime, nutritious natural food, exercise, addressing family and school issues through family therapy, parenting work, stopping bullying etc etc. The placebo aspect raises the point that to not give a pill denies people the benefit of the placebo effect. Luckily there is an alternative to antidepressants that does not risk agitation, apathy or dependency reactions. Fish Oil capsules - for which there is evidence of efficacy above placebo and showing people the literature can boost the placebo effect of the omega-3 capsule as well as them getting real benefit. Good for many systems in the body also. Posted by: Aussie child psychiatrist at March 9, 2009 10:42 PMPost a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

